Latest Regulatory Clearance News

The Australian Competition and Consumer Commission has resumed its review of DP World Australia's proposed acquisition of Silk Logistics, setting a new decision deadline that extends beyond key transaction milestones.

Breakthrough Minerals has resolved a critical regulatory issue allowing the Errolls Gold Project acquisition to proceed, with drilling set to begin next quarter targeting high-grade gold extensions.

Arizona Lithium has achieved a landmark regulatory approval for Phase 1 production at its Prairie Lithium Project, marking the first lithium brine operation sanctioned in Saskatchewan. Updated drilling and modeling have significantly expanded the project's resource base and production potential.

ITM Isotope Technologies Munich SE and Radiopharm Theranostics have entered a strategic supply agreement for the critical radioisotope Lutetium-177, underpinning Radiopharm’s clinical development of targeted cancer therapies.

Cleanaway Waste Management has received regulatory clearance from the ACCC to acquire Citywide, marking a significant step in its expansion strategy with completion expected by fiscal year-end 2025.

Euro Manganese advances its Chvaletice manganese project with key regulatory approvals, leadership appointments, and a $9.8 million capital raise, while reporting a narrowed Q3 net loss.

EBR Systems has won FDA approval for its pioneering leadless WiSE CRT System, setting the stage for a phased US commercial rollout. The company also secured key Medicare reimbursement pathways and expanded manufacturing capacity, though financial sustainability remains a concern.

PolyNovo has secured Therapeutic Goods Administration clearance for thicker versions of its NovoSorb MTX product, broadening treatment options for complex wounds in Australia.

Cleo Diagnostics has completed alpha testing of its ovarian cancer pre-surgical triage assay kits, confirming robust performance and differentiation between benign and malignant disease. The company now moves forward to assay optimisation and manufacturing scale-up, edging closer to FDA submission and commercial launch.

Orthocell has secured regulatory approval to sell its nerve repair product Remplir™ in Hong Kong well ahead of schedule, expanding its footprint across key global markets. This milestone complements recent clearances in the US, Canada, and Asia, positioning the company for significant growth in a multi-billion-dollar market.

AVJennings Limited has announced a proposed $0.655 per share acquisition scheme by PM Nominees C Pty Ltd, an investment vehicle of Proprium Capital Partners and AVID, offering shareholders a near 100% premium over recent trading prices. The scheme, supported unanimously by the board and an independent expert, awaits shareholder and court approval.

Aguia Resources reports steady underground mining at 15 tonnes per day at its Santa Barbara Gold Project, with plans to boost processing capacity to 50 tonnes per day by July 2025 and imminent gold sales.